Evidence map›Paper›PMID 38426112›Full record

ArticleFrontiers in immunology2024

Immunometabolic features of natural killer cells are associated with infection outcomes in critical illness.

Kuei-Pin Chung, Jia-Ying Su, Yi-Fu Wang, Bugi Ratno Budiarto, Yu-Chang Yeh, Jui-Chen Cheng, Li-Ta Keng, Yi-Jung Chen, Ya-Ting Lu, Yi-Hsiu Juan and 8 more

Open access · goldAbstract read
In one paragraph

Article in Frontiers in immunology, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
1.0field-weighted citation impact, top 27% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 4 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Observational
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

18 authors at 8 institutions in 2 countries.

Kuei-Pin ChungDepartment of Laboratory Medicine, National Taiwan University Hospital, Taipei, Taiwan.
Jia-Ying SuInstitute of Molecular Biology, Academia Sinica, Taipei, Taiwan.
Yi-Fu WangInstitute of Biomedical Sciences, Academia Sinica, Taipei, Taiwan.
Bugi Ratno BudiartoInstitute of Biomedical Sciences, Academia Sinica, Taipei, Taiwan.
Yu-Chang YehDepartment of Anesthesiology, National Taiwan University Hospital, Taipei, Taiwan.
Jui-Chen ChengDepartment of Integrated Diagnostics & Therapeutics, National Taiwan University Hospital, Taipei, Taiwan.
Li-Ta KengDepartment of Internal Medicine, National Taiwan University Hospital, Hsinchu, Taiwan.
Yi-Jung ChenDepartment of Laboratory Medicine, College of Medicine, National Taiwan University, Taipei, Taiwan.
Ya-Ting LuInstitute of Biomedical Sciences, Academia Sinica, Taipei, Taiwan.
Yi-Hsiu JuanDepartment of Internal Medicine, National Taiwan University Hospital, Taipei, Taiwan.
Kiichi NakahiraDepartment of Pharmacology, Nara Medical University, Kashihara, Nara, Japan.
Sheng-Yuan RuanDepartment of Internal Medicine, National Taiwan University Hospital, Taipei, Taiwan.
Jung-Yien ChienDepartment of Internal Medicine, National Taiwan University Hospital, Taipei, Taiwan.
Hou-Tai ChangDepartment of Critical Care Medicine, Far Eastern Memorial Hospital, New Taipei, Taiwan.
Jih-Shuin JerngDepartment of Internal Medicine, College of Medicine, National Taiwan University, Taipei, Taiwan.
Yen-Tsung HuangInstitute of Statistical Science, Academia Sinica, Taipei, Taiwan.
Shih-Yu ChenInstitute of Biomedical Sciences, Academia Sinica, Taipei, Taiwan.
Chong-Jen YuDepartment of Internal Medicine, National Taiwan University Hospital, Hsinchu, Taiwan.
National Taiwan University Hospital · TWInstitute of Biomedical Sciences, Academia Sinica · TWNational Taiwan University · TWAcademia Sinica · TWFar Eastern Memorial Hospital · TWInstitute of Statistical Science, Academia Sinica · TWNara Medical University · JPNational Yang Ming Chiao Tung University · TW

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Immunosuppression increases the risk of nosocomial infection in patients with chronic critical illness. This exploratory study aimed to determine the immunometabolic signature associated with nosocomial infection during chronic critical illness. We prospectively recruited patients who were admitted to the respiratory care center and who had received mechanical ventilator support for more than 10 days in the intensive care unit. The study subjects were followed for the occurrence of nosocomial infection until 6 weeks after admission, hospital discharge, or death. The cytokine levels in the plasma samples were measured. Single-cell immunometabolic regulome profiling by mass cytometry, which analyzed 16 metabolic regulators in 21 immune subsets, was performed to identify immunometabolic features associated with the risk of nosocomial infection. During the study period, 37 patients were enrolled, and 16 patients (43.2%) developed nosocomial infection. Unsupervised immunologic clustering using multidimensional scaling and logistic regression analyses revealed that expression of nuclear respiratory factor 1 (NRF1) and carnitine palmitoyltransferase 1a (CPT1a), key regulators of mitochondrial biogenesis and fatty acid transport, respectively, in natural killer (NK) cells was significantly associated with nosocomial infection. Downregulated NRF1 and upregulated CPT1a were found in all subsets of NK cells from patients who developed a nosocomial infection. The risk of nosocomial infection is significantly correlated with the predictive score developed by selecting NK cell-specific features using an elastic net algorithm. Findings were further examined in an independent cohort of COVID-19-infected patients, and the results confirm that COVID-19-related mortality is significantly associated with mitochondria biogenesis and fatty acid oxidation pathways in NK cells. In conclusion, this study uncovers that NK cell-specific immunometabolic features are significantly associated with the occurrence and fatal outcomes of infection in critically ill population, and provides mechanistic insights into NK cell-specific immunity against microbial invasion in critical illness.

Indexed as

COVID-19Cross InfectionCritical IllnessFatty AcidsHumansKiller Cells, NaturalFatty Acidschronic critical illnessCPT1ametabolismnatural killer cellsnosocomial infectionNRF1

Identifiers

PMID38426112
PMCPMC10902670
OpenAlexW4391842687

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.